The sale is pre-planned under a 10b5-1 arrangement and follows a pattern of monthly sales by the officer. No new directional signal; monitor for any change in the pattern or a filing of a new 10b5-1 plan.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $23.17entry
- T+1 · 13d ago +0.04%α −1.61% · $23.18
- T+5 · 7d ago +4.88%α +5.46% · $24.30
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Adam Crystal, an officer of Tango Therapeutics, filed a Form 144 notice of intent to sell 20,000 shares of common stock, valued at approximately $454,400, on November 2, 2026. The shares are to be acquired through the exercise of stock options, and the sale is part of a pre-existing 10b5-1 trading plan, with prior monthly sales of 27,000 shares each in August, September, and October 2026. This is a routine insider sale under a plan, not a discretionary signal.
Key Facts
- Insider Adam Crystal (Officer) filed Form 144 to sell 20,000 shares of Tango Therapeutics common stock.
- Estimated sale value: $454,400 (based on $22.72 per share, derived from the filing's total value and share count).
- Shares to be sold are acquired via exercise of stock options.
- Sale is part of a 10b5-1 trading plan; prior sales under the same plan: 27,000 shares on 10/01/2026 ($660,797), 09/01/2026 ($603,910), and 08/03/2026 ($735,518).
- Proposed sale date: November 2, 2026.
- Market cap of TNGX is $3.8B; the sale represents about 0.012% of market cap.
Financial Impact
Proposed sale of 20,000 shares valued at $454,400, representing a small fraction of market cap (0.012%) and consistent with prior monthly sales under a 10b5-1 plan.
Risk Factors
- Insider selling under a 10b5-1 plan is routine, but continued large monthly sales could indicate a desire to reduce exposure.
- No material risk identified from this filing alone.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010577 |
| Document: 0001950047-26-010577-index.html | 0001950047-26-010577 |
| Document: 0001950047-26-010577.txt | 0001950047-26-010577 |
Track record
27 reports on TNGX
3 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +29.28% at T+60 after the Jun 8, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.22 Now $24.17 +0.21% settles Feb 16
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.50 Now $24.17 +1.35% settles Feb 12
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $22.74 Now $24.17 +6.29% settles Feb 5
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $21.50 Now $24.17 +12.42% settles Feb 4
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $20.87 Now $24.17 +15.81% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Viewing Entry $23.17 Now $24.17 +4.32% settles Feb 1
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $23.34 Now $24.17 +3.56% settles Jan 21
- Aug 11, 202613w ago 8-K Bearish 6/10 Entry $25.58 to $23.18 Now $24.17 +5.51% ▲ +9.38% +4.51% vs SPY
- Aug 11, 202613w ago 8-K Bullish 7/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers